In vitro aggregation facilitates β-amyloid peptide-(25-35)-induced amnesia in the rat

European Journal of Pharmacology

Volumn 319, Issue 1, 1997, Pages 1-4

  Delobette, Stéphanie ^a   Privat, Alain ^a   Maurice, Tangui ^a  

^a INSERM   (France)

Author keywords

Amyloid type amnesia; Water maze test; Amyloid peptide (25 35)

Indexed keywords

AMYLOID BETA PROTEIN; PEPTIDE; AMYLOID BETA PROTEIN (25 35); AMYLOID BETA-PROTEIN (25-35); PEPTIDE FRAGMENT;

AMNESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; MAZE TEST; WISTAR RAT;

AMNESIA; AMYLOID BETA-PROTEIN; ANIMALS; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

EID: 0031566854     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00922-3     Document Type: Article

References (16)

1. Abe, E., F. Casamenti, L. Giovannelli, C. Scali and G. Pepeu, 1994, Administration of amyloid β-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo, Brain Res. 636, 162.
2. Cotman, C.W. and A.J. Anderson, 1995, A potential role for apoptosis in neurodegeneration and Alzheimer's disease, Mol. Neurobiol. 10, 19.
3. Dornan, W.A., D.E. Kang, A. McCampbell and E.E. Kang, 1993, Bilateral injections of beta A(25-35)+IBO into the hippocampus disrupts acquisition of spatial learning in the rat, NeuroReport 5, 165.
4. Flood, J.F., J.E. Morley and E. Roberts, 1991, Amnestic effects in mice of four synthetic peptides homologous to amyloid β protein from patients with Alzheimer disease, Proc. Natl. Acad. Sci. USA 88, 3363.
5. Flood, J.F., E. Roberts, M.A. Sherman, B.E. Kaplan and J.E. Morley, 1994, Topography of a binding site for small amnestic peptides deduced from structure-activity studies: relation to amnestic effect of amyloid β protein, Proc. Natl. Acad. Sci. USA 91, 380.
6. 25-35 peptide-mediated neurotoxicity in rat hippocampal cultures, J. Neurosci. Res. 39, 494.
7. Maurice, T., B.P. Lockhart and A. Privat, 1996, Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction, Brain Res. 706, 181.
8. McDonald, M.P., E.E. Dahl, J.B. Overmier, P. Mantyh and J. Cleary, 1994, Effects of an exogenous beta-amyloid peptide on retention for spatial learning, Behav. Neural Biol, 62, 60.
9. Nitta, A., A. Itoh, T. Hasegawa and T. Nabeshima, 1994, β-Amyloid protein-induced Alzheimer's disease animal model, Neurosci. Lett. 170, 63.
10. Paxinos, G. and C. Watson, 1986, The Rat Brain in Stereotaxic Coordinates (Academic Press, Sydney) p. 156.
11. Pike, C.J., A.J. Walencewicz, C.G. Glabe and C.W. Cotman, 1991, In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity, Brain Res. 563, 311.
12. Pike, C.J., D. Burdick, A.J. Walencewicz, C.G. Glabe and C.W. Cotman, 1993. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state, J. Neurosci. 13, 1676.
13. Selkoe, D.J., 1991, The molecular pathology of Alzheimer's disease, Neuron 6, 487.
14. Simmons, L.K., P.C. May, K.J. Tomaselli, R.E. Rydel, K.S. Fuson, E.F. Brigham, S. Wright, I. Lieberberg, G.W. Becker and D.N. Brems, 1994. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro, Mol. Pharmacol. 45, 373.
15. Winkler, J., D.J. Connor, S.A. Frautschy, C. Behl, J.J. Waite, G.M. Cole and L.J. Thal, 1994, Lack of long-term effects after β-amyloid protein injections in rat brain, Neurobiol. Aging 15, 601.
16. Yankner, B.A., L.K. Duffy and D.A. Kirschner, 1990, Neurotrophic and neurotoxic effects of amyloid β-protein: reversal by tachykinin neuropeptides, Science 250, 279.